TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 82 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,100 | +8.0% | 480 | +8.6% | 0.00% | – |
| Q2 2023 | $16,765 | +103.9% | 442 | +30.8% | 0.00% | – |
| Q1 2023 | $8,222 | -59.3% | 338 | -51.4% | 0.00% | – |
| Q4 2022 | $20,213 | -98.1% | 696 | -98.0% | 0.00% | – |
| Q3 2022 | $1,048,000 | -38.7% | 34,959 | -26.1% | 0.00% | – |
| Q2 2022 | $1,710,000 | -87.6% | 47,275 | -85.2% | 0.00% | -100.0% |
| Q1 2022 | $13,846,000 | -37.9% | 320,056 | -28.1% | 0.00% | -50.0% |
| Q4 2021 | $22,313,000 | -23.7% | 445,279 | -3.1% | 0.00% | 0.0% |
| Q3 2021 | $29,226,000 | -25.3% | 459,303 | -15.6% | 0.00% | -33.3% |
| Q2 2021 | $39,142,000 | -14.9% | 543,936 | -12.8% | 0.00% | -25.0% |
| Q1 2021 | $46,014,000 | -7.7% | 623,918 | -8.1% | 0.00% | 0.0% |
| Q4 2020 | $49,833,000 | +35.6% | 678,740 | +1.3% | 0.00% | 0.0% |
| Q3 2020 | $36,758,000 | -16.4% | 670,146 | +1.3% | 0.00% | -20.0% |
| Q2 2020 | $43,969,000 | +11.6% | 661,279 | +2.7% | 0.01% | 0.0% |
| Q1 2020 | $39,398,000 | -38.0% | 643,751 | -10.9% | 0.01% | -28.6% |
| Q4 2019 | $63,496,000 | +16.8% | 722,124 | +0.2% | 0.01% | 0.0% |
| Q3 2019 | $54,375,000 | -9.9% | 720,683 | +2.0% | 0.01% | 0.0% |
| Q2 2019 | $60,360,000 | -7.3% | 706,624 | +17.3% | 0.01% | -12.5% |
| Q1 2019 | $65,113,000 | +19.4% | 602,390 | -6.5% | 0.01% | +14.3% |
| Q4 2018 | $54,533,000 | -16.2% | 644,295 | -2.7% | 0.01% | 0.0% |
| Q3 2018 | $65,058,000 | -14.3% | 661,834 | +0.9% | 0.01% | -22.2% |
| Q2 2018 | $75,875,000 | +19.1% | 655,851 | +1.6% | 0.01% | +12.5% |
| Q1 2018 | $63,716,000 | +4.9% | 645,289 | +11.3% | 0.01% | +14.3% |
| Q4 2017 | $60,711,000 | +5.0% | 579,804 | +13.0% | 0.01% | 0.0% |
| Q3 2017 | $57,815,000 | +10.6% | 513,042 | +10.0% | 0.01% | +16.7% |
| Q2 2017 | $52,286,000 | +36.6% | 466,590 | +42.2% | 0.01% | +20.0% |
| Q1 2017 | $38,279,000 | +54.7% | 328,237 | +39.7% | 0.01% | +66.7% |
| Q4 2016 | $24,738,000 | +163.4% | 235,000 | +176.5% | 0.00% | +200.0% |
| Q3 2016 | $9,393,000 | -10.4% | 85,000 | +18.1% | 0.00% | 0.0% |
| Q2 2016 | $10,483,000 | +87.6% | 72,000 | +84.6% | 0.00% | 0.0% |
| Q1 2016 | $5,587,000 | +20.5% | 39,000 | +30.0% | 0.00% | 0.0% |
| Q4 2015 | $4,637,000 | -56.6% | 30,000 | -59.8% | 0.00% | -50.0% |
| Q3 2015 | $10,674,000 | – | 74,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 545,583 | $34,715,000 | 10.89% |
| Murchinson Ltd. | 100,000 | $6,363,000 | 3.16% |
| Eversept Partners, LP | 179,366 | $11,413,059 | 0.79% |
| BRANDES INVESTMENT PARTNERS, LP | 266,560 | $16,962,000 | 0.37% |
| Analyst IMS Investment Management Services Ltd. | 22,755 | $1,447,000 | 0.18% |
| Claret Asset Management Corp | 9,336 | $594,000 | 0.10% |
| ACADIAN ASSET MANAGEMENT LLC | 344,023 | $21,851,000 | 0.08% |
| Renaissance Technologies | 720,500 | $45,845,000 | 0.06% |
| C M BIDWELL & ASSOCIATES LTD | 1,155 | $73,000 | 0.05% |
| First Trust Direct Indexing L.P. | 3,357 | $214,000 | 0.03% |